XML 35 R24.htm IDEA: XBRL DOCUMENT
v3.25.2

SEGMENT INFORMATION (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Segment Reporting [Abstract] |
Schedule of segment reporting information |
Schedule of segment reporting information |  |  |  |  |  |  |  |
|  | Three Months Ended June 30, |
|  | 2025 |  |  | 2024 |
Total revenues |  | $ | 70,588 |  |  | $ | 26,840 |
Less: |  |  |  |  |  |  |  |
Cost of revenues (excluding amortization and depreciation) |  |  | 22,838 |  |  |  | 7,247 |
Research and development expense (excluding share-based compensation expense): |  |  |  |  |  |  |  |
Clinical trials |  |  | 122,176 |  |  |  | 9,587 |
Halo Project |  |  | 90,534 |  |  |  | 118,299 |
Desktop project |  |  | 11,700 |  |  |  | 41,524 |
Other research and development |  |  | 1,364 |  |  |  | - |
Selling, general and administrative and Salaries and Benefits expense (excluding stock based compensation and amortization expense) |  |  | 687,012 |  |  |  | 594,161 |
Amortization |  |  | 5,125 |  |  |  | 3,793 |
Stock based compensation |  |  | 572,100 |  |  |  | 308,283 |
Professional fees |  |  | 178,597 |  |  |  | 240,967 |
Interest income, net |  |  | (4,690 | ) |  |  | (66 | )
Equity in net (income) loss from equity method investees |  |  | - |  |  |  | 1,291 |
Other income |  |  | (35,181 | ) |  |  | (13,753 | )
Segment net loss |  |  | (1,580,987 | ) |  |  | (1,284,493 | )
Reconciliation of net loss |  |  |  |  |  |  |  |
Adjustments and reconciling items |  |  | - |  |  |  | - |
Consolidated net loss |  | $ | (1,580,987 | ) |  | $ | (1,284,493 | )
|  | Six Months Ended June 30, |
|  | 2025 |  |  | 2024 |
Total revenues |  | $ | 111,603 |  |  | $ | 105,511 |
Less: |  |  |  |  |  |  |  |
Cost of revenues (excluding amortization and depreciation) |  |  | 36,396 |  |  |  | 16,403 |
Research and development expense (excluding share-based compensation expense): |  |  |  |  |  |  |  |
Clinical trials |  |  | 201,578 |  |  |  | 10,825 |
Halo Project |  |  | 388,571 |  |  |  | 221,776 |
Desktop project |  |  | 35,413 |  |  |  | 41,523 |
Other research and development |  |  | 6,500 |  |  |  | 953 |
Selling, general and administrative and Salaries and Benefits expense (excluding stock based compensation and amortization expense) |  |  | 1,309,958 |  |  |  | 1,239,882 |
Amortization |  |  | 9,912 |  |  |  | 6,454 |
Stock based compensation |  |  | 1,208,945 |  |  |  | 469,632 |
Professional fees |  |  | 546,413 |  |  |  | 468,796 |
Interest income, net |  |  | (5,793 | ) |  |  | (370 | )
Equity in net (income) loss from equity method investees |  |  | 1,048 |  |  |  | (4,492 | )
Other income |  |  | (58,014 | ) |  |  | (40,221 | )
Segment net loss |  |  | (3,569,324 | ) |  |  | (2,325,650 | )
Reconciliation of net loss |  |  |  |  |  |  |  |
Adjustments and reconciling items |  |  | - |  |  |  | - |
Consolidated net loss |  | $ | (3,569,324 | ) |  | $ | (2,325,650 | )

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration